Matthew Z Guo

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Combination Therapy

Small Cell Lung Cancer

Dna Damage Response

Top Venues

OncoTargets and therapy

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Z Guo, Kristen A Marrone, Alexander Spira, Samuel Rosner
Adagrasib: a novel inhibitor for KRAS G12C -mutated non-small-cell lung cancer. Future oncology (London, England) (2023)
Catalina Pereira, Gerardo A Arroyo-Martinez, Matthew Z Guo, Michael S Downey, Emma R Kelly, Kathryn J Grive, Shantha K Mahadevaiah, Jennie R Sims, Vitor M Faca, Charlton Tsai, Carl J Schiltz, Niek Wit, Heinz Jacobs, Nathan L Clark, Raimundo Freire, James M A Turner, Amy M Lyndaker, Miguel A Brieno-Enriquez, Paula E Cohen, Marcus Bustamante Smolka, Robert Samuel Weiss
Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis. eLife 11 (2022)
Amanda R Loehr, Timothy M Pierpont, Eric Gelsleichter, Anabella Maria D Galang, Irma R Fernandez, Elizabeth S Moore, Matthew Z Guo, Andrew D Miller, Robert Samuel Weiss
Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors. Cancers 13 (9) (2021)
Matthew Z Guo, Kristen A Marrone, Alexander Spira, David M Waterhouse, Susan C Scott
Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics. OncoTargets and therapy 14 (2021)